BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 1 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $739,175 | -45.0% | 51,296 | -37.4% | 0.52% | -37.4% |
Q2 2023 | $1,344,798 | -1.9% | 81,900 | -0.1% | 0.83% | -5.7% |
Q1 2023 | $1,370,220 | +8.2% | 82,000 | -50.0% | 0.88% | -21.4% |
Q4 2022 | $1,266,525 | +3.5% | 164,000 | +100.0% | 1.12% | -27.6% |
Q3 2022 | $1,224,000 | -9.1% | 82,000 | 0.0% | 1.55% | +21.3% |
Q2 2022 | $1,347,000 | -56.5% | 82,000 | -23.4% | 1.28% | +30.6% |
Q2 2021 | $3,094,000 | -52.9% | 107,000 | -57.2% | 0.98% | +3.4% |
Q1 2021 | $6,574,000 | – | 250,000 | – | 0.95% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
Matisse Capital | 51,296 | $739,175 | 0.52% |
Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |